Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Forkhead box protein B2 (FOXB2) is a member of the forkhead box (FOX) family of transcription factors, defined by its role in sequence-specific DNA binding and regulation of transcription by RNA polymerase II. FOXB2 is implicated in both development and oncogenesis, with context-dependent functions. In certain cancer contexts, such as advanced prostate cancer, FOXB2 acts as a potent activator of Wnt signaling by inducing expression of several Wnt ligands, notably WNT7B, driving neuroendocrine differentiation and malignant progression. This mechanism does not rely on classical Wnt co-receptors and involves key transcriptional cofactors such as YY1, JUN, and DDX5. Conversely, in pancreatic ductal adenocarcinoma, FOXB2 is epigenetically silenced, and its expression has tumor-suppressive effects, inhibiting β-catenin and reducing stem-like malignancy. FOXB2 is also active during embryogenesis, with distinct expression dynamics suggesting a role in neural patterning and organogenesis[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Forkhead box protein B2 (FOXB2).